The root of many evils: Indolent large granular lymphocyte leukaemia and associated disorders

Hematological Oncology

Volumn 28, Issue 3, 2010, Pages 105-117

  Zhang, Ranran ^a   Shah, Mithun Vinod ^a   Loughran Jr , Thomas P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Large granular lymphocyte leukaemia; Non malignant clonal lymphocyte expansion

Indexed keywords

DEXAMETHASONE; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; MITOXANTRONE; STEROID;

AGED; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CELL EXPANSION; DISEASE ASSOCIATION; HEMATOLOGIC DISEASE; HUMAN; LARGE GRANULAR LYMPHOCYTE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; NEOPLASM; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; IMMUNOLOGY; LYMPHOCYTE; NATURAL KILLER CELL; PATHOLOGY;

HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; LYMPHOCYTES;

EID: 77957311263     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.917     Document Type: Review

References (163)

1. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82(1): 1-14.
2. Timonen T, Ortaldo JR, Herberman RB. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981; 153(3): 569-582.
3. Young LHY, Liu CC, Joag S, Rafii S, Young JDE. How lymphocytes kill. Annu Rev Med 1990; 41(1): 45-54.
4. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20(1): 323-370.
5. Di Santo JP. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006; 24(1): 257-286.
6. Caligiuri MA. Human natural killer cells. Blood 2008; 112(3): 461-469.
7. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9(5): 495-502.
8. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9(5): 503-510.
9. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22(11): 633-640.
10. Lauritsen JPH, Haks MC, Lefebvre JM, Kappes DJ, Wiest DL. Recent insights into the signals that control alphabeta/gamma-delta-lineage fate. Immunol Rev 2006; 209(1): 176-190.
11. Thedrez A, Sabourin C, Gertner J, Devilder M-C, Allain-Maillet S, Fournie J-J, et al. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 2007; 215(1): 123-135.
12. Liu C-C, Young LHY, Young JD-E. Lymphocyte-mediated cytolysis and disease. N Engl J Med 1996; 335(22): 1651-1659.
13. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006; 6(12): 940-952.
14. Bolitho P, Voskoboinik I, Trapani JA, Smyth MJ. Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin Immunol 2007; 19(3): 339-347.
15. Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC. Granzyme B: a natural born killer. Immunol Rev 2003; 193(1): 31-38.
16. Krueger A, Fas SC, Baumann S, Krammer PH. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 2003; 193(1): 58-69.
17. Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996; 157(7): 2909-2915.
18. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002; 296(5573): 1635-1636.
19. Clark R, Griffiths GM. Lytic granules, secretory lysosomes and disease. Curr Opin Immunol 2003; 15(5): 516-521.
20. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995; 181(2): 781-786.
21. Montel AH, Bochan MR, Hobbs JA, Lynch DH, Brahmi Z. Fas involvement in cytotoxicity mediated by human NK cells. Cell Immunol 1995; 166(2): 236-246.
22. Ida H, Utz PJ, Anderson P, Eguchi K. Granzyme B and natural killer (NK) cell death. Mod Rheumatol 2005; 15(5): 315-322.
23. Laforge M, Bidere N, Carmona S, Devocelle A, Charpentier B, Senik A. Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B. J Immunol 2006; 176(7): 3966-3977.
24. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, et al. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 2002; 100(12): 4098-4107.
25. Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, et al. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of C D8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily. Blood 2002; 99(5): 1706-1714.
26. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003; 15(5): 533-543.
27. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist 2006; 11(3): 263-273.
28. Shah MV, Zhang R, Irby R, Kothapalli R, Liu X, Arrington T, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008; 112(3): 770-781.
29. Choi YL, Makishima H, Ohashi J, Yamashita Y, Ohki R, Koinuma K, et al. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions. Leukemia 2004; 18(3): 556-565.
30. Yang J, Epling-Burnette PK, Painter JS, Zou J, Bai F, Wei S, et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111(3): 1610-1616.
31. Kothapalli R, Bailey R, Kusmartseva I, Mane S, Epling-Burnette P, Loughran TP Jr. Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 2003; 22(1): 33-39.
32. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia. Blood 1998; 92(12): 4771-4777.
33. Liu JH, Wei S, Lamy T, Li Y, Epling-Burnette PK, Djeu JY, et al. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 2002; 100(4): 1449-1453.
34. Epling-Burnette PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004; 103(9): 3431-3439.
35. Chen X, Bai F, Sokol L, Zhou J, Ren A, Painter JS, et al. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009; 113(14): 3226-3234.
36. Kothapalli R, Nyland S, Kusmartseva I, Bailey R, McKeown T, Loughran TP Jr. Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia. Int J Oncol 2005; 26(2): 529-535.
37. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987; 66(5): 397-405.
38. Aisenberg AC, Utility of gene rearrangements in lymphoid malignancies. Annu Rev Med 1993; 44(1): 75-84.
39. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84(1): 51-55.
40. Hart DN, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells [see comments]. Blood 1992; 79(8): 2116-2123.
41. Gentile TC, Uner AH, Hutchison RE, Wright J, Ben-Ezra J, Russell EC, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia [see comments]. Blood 1994; 84(7): 2315-2321.
42. Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology 2001; 2001(1): 259-281.
43. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control 1998; 5(1): 25-33.
44. Alekshun T, Sokol L. Diseases of large granular lymphocytes. Cancer Control. 2007; 14(2): 141-150.
45. Roullet MR, Cornfield DB. Large natural killer cell lymphoma arising from an indolent natural killer cell large granular lymphocyte proliferation. Arch Pathol Lab Med 2006; 130(11): 1712-1714.
46. Huang Q, Chang KL, Gaal KK, Weiss LM. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder. Am J Surg Pathol 2005; 29(11): p. 1540-1543.
47. Clambey ET, van Dyk LF, Kappler JW, Marrack P. Non-malignant clonal expansions of CD8+ memory T cells in aged individuals. Immunol Rev 2005; 205(1): 170-189.
48. Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating C D94: NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101(8): 3198-3204.
49. Viny AD, Lichtin A, Pohlman B, Loughran T, Maciejewski J. Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 2008; 49(5): 932-938.
50. Sandberg Y, Almeida J, Gonzalez M, Lima M, Barcena P, Szczepanski T, et al. TCR[gamma][delta]+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCR[gamma][delta]+ T-cells. Leukemia 2006; 20(3): 505-513.
51. Papadaki T, Stamatopoulos K, Kosmas C, Paterakis G, Kapsimali V, Kokkini G, et al. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia 2002; 16(10): 2167-2169.
52. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84(5): 1620-1627.
53. Marolleau JP, Henni T, Gaulard P, Le Couedic JP, Gourdin MF, Divine M, et al. Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment. Blood 1988; 72(2): 655-660.
54. Papadaki T, Stamatopoulos K, Stavroyianni N, Paterakis G, Phisphis M, Stefanoudaki-Sofianatou K. Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases. Leuk Res 2002; 26(6): 597-600.
55. Sandberg Y, Dezentje VO, Szuhai K, van Houte AJ, Tielemans D, Wolvers-Tettero ILM, et al. Clonal T- and natural killer-cell large granular lymphocyte proliferations in a single patient established by array-based comparative genomic hybridization analysis. Leukemia 2006; 20(12): 2212-2214.
56. Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004; 9(3): 247-258.
57. Zambello R, Semenzato G. Large granular lymphocytosis. Haematologica 1998; 83(10): 936-942.
58. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999; 106(4): 960-966.
59. Burks EJ, Loughran JTP. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006; 20(5): 245-266.
60. Morice WG, Kurtin PJ, Tefferi A, Hanson CA. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 2002; 99(1): 268-274.
61. Wlodarski MW, Nearman Z, Jiang Y, Lichtin A, Maciejewski JP. Clonal predominance of CD8+ T cells in patients with unexplained neutropenia. Exp Hematol 2008; 36(3): 293-300.
62. Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, et al. Chronic neutropenia mediated by Fas ligand. Blood 2000; 95(10): 3219-3222.
63. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology 2004; 2004(1): 63-79.
64. Go RS, Li C-Y, Tefferi A, Phyliky RL. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001; 98(2): 483-485.
65. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities [see comments]. Blood 1996; 87(7): 3000-3006.
66. Go RS, Lust JA, Phyliky RL. Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol 2003; 40(3): 196-200.
67. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 1998; 51(9): 672-675.
68. Masuda M, Teramura M, Matsuda A, Bessho M, Shimamoto T, Ohyashiki K, et al. Clonal T cells of pure red-cell aplasia. Am J Hematol 2005; 79(4): 332-333.
69. Tse E, Chan JCW, Pang A, Au WY, Leung AYH, Lam CCK, et al. Fludarabine, mitoxantrone and dexamethasone as firstline treatment for T-cell large granular lymphocyte leukemia. Leukemia 2007; 21(10): 2225-2226.
70. Kwong YL, Wong KF, Chan LC, Liang RH, Chan JK, Lin CK, et al. Large granular lymphocyte leukemia. A study of nine cases in a Chinese population. Am J Clin Pathol 1995; 103(1): 76-81.
71. Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340(4): 278-284.
72. Yamada O, Yun-Hua W, Motoji T, Mizoguchi H. Clonal T-cell proliferation causing pure red cell aplasia in chronic B-cell lymphocytic leukaemia: successful treatment with cyclosporine following in vitro abrogation of erythroid colony-suppressing activity. Br J Haematol 1998; 101(2): 335-337.
73. Au W-Y, Lam CCK, Chim C-S, Pang AWK, Kwong Y-L. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. Leuk Res 2005; 29(10): 1213-1215.
74. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75(3): 373-376.
75. Chisaka H, Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol 2003; 13(6): 347-359.
76. Kondo H, Mori A, Watanabe J, Takada J, Takahashi Y, Iwasaki H. Pure red cell aplasia associated with parvovirus B19 infection in T-large granular lymphocyte leukemia. Leuk Lymphoma 2001; 42(6): 1439-1443.
77. Ergas D, Resnitzky P, Berrebi A. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia [letter]. Blood 1996; 87(8): 3523-3524.
78. Akashi K, Shibuya T, Taniguchi S, Hayashi S, Iwasaki H, Teshima T, et al. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. Br J Haematol 1999; 107(3): 670-673.
79. Karadimitris A, Li K, Notaro R, Araten DJ, Nafa K, Thertulien R, et al. Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001; 115(4): 1010-1014.
80. Go RS, Tefferi A, Li C-Y, Lust JA, Phyliky RL. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia. Blood 2000; 96(10): 3644-3646.
81. Risitano AM, Maciejewski JP, Muranski P, Wlodarski M, O'Keefe C, Sloand EM, et al. Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 2005; 19(2): 217-222.
82. Lai DW, Loughran TP Jr, Maciejewski JP, Sasu S, Song SX, Epling-Burnette PK, et al. Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia. Leuk Res 2008; 32(5): 823-827.
83. Wex H, Aumann V, Häusler M, Vorwerk P, Mittler U. Chronic natural killer cell lymphocytosis is associated with elevated cytotoxic activity of natural killer cells. J Pediatr Hematol Oncol 2005; 27(2): 85-89.
84. Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY, Witzig TE. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Dermatol 1996; 93(4): 810-812.
85. Epperson DE, Nakamura R, Saunthararajah Y, Melenhorst J, Barrett AJ. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process. Leuk Res 2001; 25(12): 1075-1083.
86. Saunthararajah Y, Molldrem JJ, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L, et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112(1): 195-200.
87. Maciejewski JP, O'Keefe C, Gondek L, Tiu R. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol 2007; 45(1): 5-14.
88. Saitoh T, Karasawa M, Sakuraya M, Norio N, Junko T, Shirakawa K, et al. Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity. Eur J Haematol 2000; 65(4): 272-275.
89. Tefferi A, Li C-Y. Bone marrow granulomas associated with chronic natural killer cell lymphocytosis. Am J Hematol 1997; 54(3): 258-262.
90. Cartwright GE, Athens JW, Wintrobe MM. Analytical review: the kinetics of granulopoiesis in normal man. Blood 1964; 24(6): 780-803.
91. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, et al. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998; 80(2): 173-195.
92. Klonizakis I, Peters AM, Fitzpatrick ML, Kensett MJ, Lewis SM, Lavender JP. Spleen function and platelet kinetics. J Clin Pathol 1981; 34(4): 377-380.
93. Gentile TC, Loughran TP Jr. Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia. Leuk Lymphoma 1996; 23(3-4): 405-408.
94. Subbiah V, Viny AD, Rosenblatt S, Pohlman B, Lichtin A, Maciejewski JP. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp Hematol 2008; 36(9): 1078-1083.
95. Loughran TP Jr, Clark EA, Price TH, Hammond WP. Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 1986; 68(5): 1082-1087.
96. Loughran TP Jr, Hammond WP IV. Adult-onset cyclic neutropenia is a benign neoplasm associated with clonal proliferation of large granular lymphocytes. J Exp Med 1986; 164(6): 2089-2094.
97. Dale DC, Hammond WP. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2(3): 178-185.
98. Füreder W, Mitterbauer G, Thalhammer R, Geissler K, Panzer S, Krebs M, et al. Clonal T cell-mediated cyclic thrombocytopenia. Br J Haematol 2002; 119(4): 1059-1061.
99. Fogarty PF, Stetler-Stevenson M, Pereira A, Dunbar CE. Large granular lymphocytic proliferation-associated cyclic thrombocytopenia. Am J Hematol 2005; 79(4): 334-336.
100. Foley C, Mackey M. Dynamic hematological disease: a review. J Math Biol 2009; 58(1): 285-322.
101. Apostu R, Mackey MC. Understanding cyclical thrombocytopenia: a mathematical modeling approach. J Theor Biol 2008; 251(2): 297-316.
102. Gaur S, Mansoor S, Aish L. T-cell large granular lymphocytic leukemia and hereditary hemochromatosis: a fortuitous association? Am J Hematol 2005; 78(4): 299-301.
103. Cardoso C, Porto G, Lacerda R, Resende D, Rodrigues P, Bravo F, et al. T-Cell receptor repertoire in hereditary hemochromatosis: a study of 32 hemochromatosis patients and 274 healthy subjects. Hum Immunol 2001; 62(5): 488-499.
104. Vanness ER, Davis MDP, Tefferi A. Cutaneous findings associated with chronic natural killer cell lymphocytosis. Int J Dermatol 2002; 41(12): 852-857.
105. Ishida T, Sadaoka K, Takeyabu K, Yamaguchi E, Isobe H, Kawakami Y, et al. Lymphoproliferative disorder of granular lymphocytes (natural killer cell type) with interstitial pneumonia in a patient with familial pancytopenia. Intern Med 1996; 35(4): 331-336.
106. Lutskiy MI, Beardsley DS, Rosen FS, Remold-O'Donnell E. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood 2005; 106(8): 2815-2817. (Pubitemid 41510758)
107. Boztug K, Baumann U, Ballmaier M, Webster D, Sandrock I, Jacobs R, et al. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Haematologica 2007; 92(3): e43-e45.
108. Du W, Kumaki S, Uchiyama T, Yachie A, Yeng LC, Kawai S, et al. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient. Hum Mutat 2006; 27(4): 370-375.
109. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006; 117(4): 725-738.
110. Bourgault-Rouxel AS, Loughran TP Jr, Zambello R, Epling-Burnette PK, Semenzato G, Donadieu J, et al. Clinical spectrum of [gamma][delta]+ T cell LGL leukemia: analysis of 20 cases. Leuk Res 2008; 32(1): 45-48.
111. Starkebaum G. Leukemia of large granular lymphocytes and rheumatoid arthritis. Am J Med 2000; 108(9): 744-745.
112. Samanta A, Grant I, Nichol FE, Pringle JH, Wood JK, Campbell AC. Large granular lymphocytosis associated with rheumatoid arthritis. Ann Rheum Dis 1988; 47(10): 873-875.
113. Horiuchi T, Hirokawa M, Satoh K, Kitabayashi A, Muira AB. Clonal expansion of γδ-T lymphocytes in an HTLV-I carrier, associated with chronic neutropenia and rheumatoid arthritis. Ann Hematol 1999; 78(2): 101-104.
114. Prochorec-Sobieszek M, Chelstowska M, Rymkiewicz G, Majewski M, Warzocha K, Maryniak R. Biclonal T-cell receptor gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthritis. Leuk Lymphoma 2008; 49(4): 828-831.
115. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423(6937): 356-361.
116. Machatschek JN, Westerman D, Prince HM, Seymour JF. A case of clinical indolent natural killer cell lineage large granular lymphocytic leukemia in a patient with rheumatoid arthritis. Leuk Lymphoma 2003; 44: 1223-1227.
117. Abdou NI, NaPombejara C, Balentine L, Abdou NL. Suppressor cell-mediated neutropenia in Felty's syndrome. J Clin Invest 1978; 61(3): 738-743.
118. Kang YM, Zhang X, Wagner UG, Yang H, Beckenbaugh RD, Kurtin PJ, et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 2002; 195(10): 1325-1336.
119. Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, Florea SM, et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med 2001; 193(2): 219-232.
120. Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, et al. Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood 2007; 109(12): 5168-5177.
121. Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, et al. Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci USA 2008; 105(42): 16308-16313.
122. Kim GS, Youn JK, Kim JD, Hyun Kim N. Natural killer cell activity in rheumatoid arthritis measured by a single cell cytotoxicity assay. Yonsei Med J 1988; 29(2): 160-165.
123. Pridgeon C, Lennon GP, Pazmany L, Thompson RN, Christmas SE, Moots RJ. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94-bright,CD158negative phenotype. Rheumatology 2003; 42(7): 870-878.
124. Rossoff LJ, Genovese J, Coleman M, Dantzker DR. Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy. Chest 1997; 112(2): 551-553.
125. Epling-Burnette PK, Sokol L, Chen X, Bai F, Zhou J, Blaskovich MA, et al. Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 2008; 112(12): 4694-4698.
126. Mallo S, Coto P, Caminal L, Rayon C, Balbim M, Sanchez-Del Rio J, et al. Generalized pruritus as presentation of T-cell large granular lymphocyte leukaemia. Clin Exp Dermatol 2008; 33(3): 348-349.
127. Meyer N, Dufour J, Lamy T, Chevrant-Breton J. Cutaneous vasculitis and T-large granular lymphocyte leukaemia with parallel evolution. Br J Dermatol 2007; 157(3): 631-633.
128. Magro C, Crowson AN, Kovatich A, Burns F. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002; 33(8): 788-795.
129. Shvidel L, Duksin C, Tzimanis A, Shtalrid M, Klepfish A, Sigler E, et al. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. Hematol J 2002; 3(1): 27-32.
130. Granjo E, Lima M, Correia T, Lisboa C, Magalhaes C, Cunha N, et al. Cd8(+)vbeta5.1(+) large granular lymphocyte leukemia associated with autoimmune cytopenias, rheumatoid arthritis and vascular mammary skin lesions: successful response to 2-deoxycoformycin. Hematol Oncol 2002; 20(2): 87-93.
131. Nasa G, Littera R, Cocco E, Battistini L, Marrosu M, Contu L. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol 2004; 83(6): 403-405.
132. Au WY, Mak W, Ho SL, Leung SY, Kwong YL. Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia. Neurology 2004; 63(3): 588-589.
133. Noguchi M, Yoshita M, Sakai K, Matsumoto Y, Arahata M, Ontachi Y, et al. Peripheral neuropathy associated with chronic natural killer cell lymphocytosis. J Neurol Sci 2005; 232(1-2): 119-122.
134. Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006; 354(9): 942-955.
135. Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology 2003; 308(1): 1-12.
136. Rosche B, Jacobsen M, Cepok S, Barth P, Sommer N, Hemmer B. Myositis in a patient with large granular leukocyte leukemia. Muscle Nerve 2004; 29(6): 873-877.
137. Friedman J, Schattner A, Shvidel L, Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but underrecognized association. Semin Arthritis Rheum 2006; 35(5): 306-311.
138. Ergas D, Tsimanis A, Shtalrid M, Duskin C, Berrebi A. T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjoren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. Am J Hematol 2002; 69(2): 132-134.
139. Marlton P, Taylor K, Elliott S, McCormack J. Monoclonal large granular lymphocyte proliferation in SLE with HTLV-I seroreactivity. Intern Med J 1992; 22(1): 54-55.
140. Saitoh T, Matsushima T, Kaneko Y, Yokohama A, Handa H, Tsukamoto N, et al. T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL. Ann Hematol 2008; 87(7): 585-586.
141. Molitor J, Saint-Louis J, Louvet C, Vachon A, Vincent L, Beaulieu R. Large granular T-cell lymphocytic leukemia disclosed by bilateral uveitis: association with celiac disease. Rev Med Interne 1997; 18(3): 238-239.
142. Fox RI. Sjoren's syndrome. Lancet 2005; 366(9482): 321-331.
143. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350(20): 2068-2079.
144. Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr Opin Rheumatol 2005; 19(1): 44-48.
145. McIntosh RS, Watson PF, Weetman AP. Analysis of the T cell receptor V{alpha} repertoire in Hashimoto's thyroiditis: evidence for the restricted accumulation of CD8+ T cells in the absence of CD4+ T cell restriction. J Clin Endocrinol Metab 1997; 82(4): 1140-1146.
146. Wouters CHP, Diegenant C, Ceuppens JL, Degreef H, Stevens EAM. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Br J Dermatol 2004; 150(4): 693-700.
147. Peterson P, Peltonen L. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views onmolecular basis of autoimmunity. J Autoimmun 2005; 25: (Supplement 1): 49-55.
148. Cikes N, Bosnic D, Sentic M. Non-MS autoimmune demyelination. Clin Neurol Neurosurg 2008; 110(9): 905-912.
149. Schiess N, Pardo CA. Hashimoto's encephalopathy. Ann N Y Acad Sci 2008; 1142(The Year in Neurology 2008): 254-265.
150. Borgonovo G, Secondo V, Varaldo E, Pistoia V, Gobbi M, Mattioli FP. Large granular lymphocyte leukemia associated with hepatocellular carcinoma: a case report. Haematologica 1996; 81(2): 172-174.
151. Rossi D, Franceschetti S, Capello D, Conconi A, Casadio C, Valente G, et al. Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia. Leuk Res 2007; 31(7): 1019-1021.
152. Manola KN, Sambani C, Karakasis D, Kalliakosta G, Harhalakis N, Papaioannou M. Leukemias associated with Turner syndrome: report of three cases and review of the literature. Leuk Res 2008; 32(3): 481-486.
153. Au WY, Lam CCK, Lie AKW, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol 2003; 120(4): 626-630.
154. Sabnani I, Zucker MJ, Tsang P, Palekar S. Clonal T-large granular lymphocyte proliferation in solid organ transplant recipients. Transplant Proc 2006; 38(10): 3437-3440.
155. Ricalton NS, Roberton C, Norris JM, Rewers M, Hamman RF, Kotzin BL. Prevalence of CD8+ T-cell expansions in relation to age in healthy individuals. J Gerontol A Biol Sci Med Sci 1998; 53(3): B196-B203.
156. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 2005; 205(1): 147-157.
157. Re F, Poccia F, Donnini A, Bartozzi B, Bernardini G, Provinciali M. Skewed representation of functionally distinct populations of V[gamma]9V[delta]2 T lymphocytes in aging. Exp Gerontol 2005; 40(1-2): 59-66.
158. Argentati K, Re F, Donnini A, Tucci MG, Franceschi C, Bartozzi B, et al. Numerical and functional alterations of circulating {gamma}{delta} T lymphocytes in aged people and centenarians. J Leukoc Biol 2002; 72(1): 65-71.
159. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, et al. The immune system in extreme longevity. Exp Gerontol 2008; 43(2): 61-65.
160. Chidrawar S, Khan N, Chan YLT, Nayak L, Moss P. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing 2006; 3(1): 10.
161. Hsu H-C, Scott DK, Mountz JD. Impaired apoptosis and immune senescence: cause or effect? Immunol Rev 2005; 205(1): 130-146.
162. Melenhorst JJ, Brummendorf TH, Kirby M, Lansdorp PM, Barrett AJ. CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis. Leuk Res 2001; 25(8): 699-708.
163. Lesesve JF, Feugier P, Lamy T, Bene MC, Gregoire MJ, Lenormand B, et al. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia. Clin Lab Haematol 2000; 22(2): 121-122.